Flow cytometric analysis of cervical lymph node tumor cells: CD43 and B220
| . | Q1: B220+, CD43− . | Q2: B220+, CD43+ . | Q3: B220−, CD43− . | Q4: B220−, CD43+ . |
|---|---|---|---|---|
| LMP2A/λ-MYC CT (n = 17) | 9.4 ± 10.2 | 86.8 ± 10.0 | 0.3 ± 0.3 | 3.5 ± 3.7 |
| λ-MYC CT (IgM+) (n = 7) | 14.4 ± 27.3 | 83.9 ± 27.4 | 0.2 ± 0.4 | 1.5 ± 1.8 |
| λ-MYC CT (IgM−) (n = 5) | 3.8 ± 3.6 | 93.6 ± 4.1 | 0.4 ± 0.4 | 2.1 ± 1.9 |
| . | Q1: B220+, CD43− . | Q2: B220+, CD43+ . | Q3: B220−, CD43− . | Q4: B220−, CD43+ . |
|---|---|---|---|---|
| LMP2A/λ-MYC CT (n = 17) | 9.4 ± 10.2 | 86.8 ± 10.0 | 0.3 ± 0.3 | 3.5 ± 3.7 |
| λ-MYC CT (IgM+) (n = 7) | 14.4 ± 27.3 | 83.9 ± 27.4 | 0.2 ± 0.4 | 1.5 ± 1.8 |
| λ-MYC CT (IgM−) (n = 5) | 3.8 ± 3.6 | 93.6 ± 4.1 | 0.4 ± 0.4 | 2.1 ± 1.9 |
Values are percentages.